Medscape Podcasts
Keeping Current
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: keepingcurrent.webmd.libsynpro.com
Autor
Medscape Podcasts
Kategoria
Strona podcastu
Ostatni odcinek
30 cze 2026
Gdzie słuchać?
Podcasty w aplikacji Replaio Radio Już wkrótcePodcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów
Odcinki
Tumor-Like Masses, Abdominal Swelling, Pancreatic Involvement: Making Sense of IgG4-Related Disease, a Multiorgan Fibroinflammatory Condition 13.08.2025 27:55
Immunoglobulin G4-related disease (IgG4-RD) isn't always obvious; join our expert roundtable to learn when to suspect it and how to detect flares. Credit available for this activity expires: 8/12/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002730?ecd=bdc_podcast_libsyn_mscpedu
Monitoring ESR1 ctDNA During First-Line Care of HR-Positive Advanced Breast Cancer: A New Approach 08.08.2025 36:55
When do you first test for ESR1 mutation in hormone receptor (HR)-positive advanced breast cancer (ABC)? Credit available for this activity expires: 8/7/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002782?ecd=bdc_podcast_libsyn_mscpedu
ADA 2025 Highlights: The Weight of Evidence for Emerging Combination Therapies in Obesity and Diabetes Care 01.08.2025 31:48
Stay up to date with the latest on combination therapies for weight reduction presented at ADA 2025. Credit available for this activity expires: 7/28/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002750?ecd=bdc_podcast_libsyn_mscpedu
Advancing Treatment for HER2-Positive Advanced Breast Cancer: Expert Analysis of the Latest Developments 01.08.2025 16:32
Join this program to get the latest commentary on updates in HER2-positive advanced and metastatic breast cancer. Credit available for this activity expires: 7/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002765?ecd=bdc_podcast_libsyn_mscpedu
Personalized Pathways: Tailoring Care for Patients With Newly Diagnosed Multiple Myeloma 30.07.2025 50:24
How familiar are you with the latest strategies to individualize treatment for patients with newly diagnosed multiple myeloma (NDMM)? Credit available for this activity expires: 7/25/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002741?ecd=bdc_podcast_libsyn_mscpedu
Quickfire Updates on Gastric/GEJ Cancers: Latest Data in Perioperative Immunotherapy 21.07.2025 19:09
Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways. Credit available for this activity expires: 7/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu
IgG-Mediated Autoimmune Disorders: A Clinical Update on Novel Therapies Targeting FcRn 18.07.2025 12:55
New therapies for myositis and Sjögren disease: are you up to date? Credit available for this activity expires: 7/15/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002691?ecd=bdc_podcast_libsyn_mscpedu
Breast Cancer Care in 2025: Breakthroughs and Takeaways From Chicago 17.07.2025 36:31
Join us for an in-depth update on recent clinical trial data on all advanced and metastatic breast cancer (BC) subtypes. Credit available for this activity expires: 06/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002644?ecd=bdc_podcast_libsyn_mscpedu
Fresh Perspectives in Thyroid Eye Disease 16.07.2025 37:27
Can you spot the signs of active disease? Learn how to assess, manage, and coordinate care. Credit available for this activity expires: 07/09/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002654?ecd=bdc_podcast_libsyn_mscpedu
The Evolution of Antibody-Drug Conjugate Therapy for Gastric/GEJ Cancers: Latest Data and Clinical Implications 14.07.2025 34:41
Could the latest data in novel antibody-drug conjugates reshape your treatment approach for patients with gastric cancer? Credit available for this activity expires: 7/1/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002638?ecd=bdc_podcast_libsyn_mscpedu
Shared Decision-Making in Epilepsy Today 30.06.2025 51:42
How do you talk to patients about conception, risks to offspring during epilepsy treatment, mortality, lifestyle and brain health? Credit available for this activity expires: 6/27/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002600?ecd=bdc_podcast_libsyn_mscpedu
Frontline Frontiers: Revolutionizing Extensive-Stage SCLC Care Through Treatment Innovation 30.06.2025 35:32
Are you up-to-date on the novel, practice-changing combination strategies for first-line maintenance treatment? Credit available for this activity expires: 6/13/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002626?ecd=bdc_podcast_libsyn_mscpedu
Navigating PD-L1 Testing and Patient-Centered Treatment of Gastroesophageal Cancer: A Guide for All Oncology Settings 30.06.2025 48:59
Do you know why programmed death-ligand 1 (PD-L1) testing and targeted therapy are so important for improving patient care? Credit available for this activity expires: 6/27/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002597?ecd=bdc_podcast_libsyn_mscpedu
Under the Skin: Revolutionizing Immunotherapy Delivery in Lung Cancer 25.06.2025 15:39
How ready are you to optimally manage subcutaneous immunotherapy in your practice? Credit available for this activity expires: 6/25/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002630?ecd=bdc_podcast_libsyn_mscpedu
One Team, One Goal: The Key to Better Patient Outcomes in Early Breast Cancer Management 06.06.2025 37:57
Are you up to date with management strategies for early breast cancer? Credit available for this activity expires: 06/03/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002593?ecd=bdc_podcast_libsyn_mscpedu
Collaborative Management of EGFR-Mutated Advanced NSCLC: A Patient–Care Team Journey 30.05.2025 50:52
How well are you managing your patients with the new intensification strategies for EGFR -mutated advanced non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 5/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002547?ecd=bdc_podcast_libsyn_mscpedu
New Considerations in Managing Family Planning in Multiple Sclerosis 08.05.2025 55:15
What are the key challenges that women with multiple sclerosis (MS) face during their pregnancy journey? Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002489?ecd=bdc_podcast_libsyn_mscpedu
Advancing Precision Oncology: Recent Progress and Future Outlook 01.05.2025 39:04
Did you know that there are several approved tumor agnostic therapies? Join our experts for an in-depth discussion. Credit available for this activity expires: 04/30/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-precision-oncology-recent-progress-and-future-2025a1000a6b?ecd=bdc_podcast_libsyn_mscpedu
Advanced HER2-Positive Gastric/GEJ Cancers: Expert Insights on Current and Future Strategies 30.04.2025 38:09
Do you know the latest strategies to optimize care for HER2-positive gastric and gastroesophageal junction (GEJ) cancers? Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002494?ecd=bdc_podcast_libsyn_mscpedu
Decoding PD-L1 Scoring: Guiding Immunotherapy for Gastroesophageal Cancers 29.04.2025 38:21
Did you know that tumor area positivity (TAP) scoring can be completed up to 6 times faster than combined positive score (CPS)? Credit available for this activity expires: 4/23/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002476?ecd=bdc_podcast_libsyn_mscpedu
Patient-Centered Paroxysmal Nocturnal Hemoglobinuria Treatment & the Role of Terminal Complement Inhibitors 31.03.2025 36:54
Do you know how important treatment convenience and quality of life are to patients when selecting paroxysmal nocturnal hemoglobinuria (PHN) therapy? Credit available for this activity expires: 3/31/2026 Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002332? ecd=bdc_podcast_libsyn_mscpedu
Are We Undertreating Depression in People Living With Epilepsy? 31.03.2025 15:36
Eight answers to help you do better for these patients. Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002029?ecd=bdc_podcast_libsyn_mscpedu
Pearls on Retina Biomarkers for Clinical Practice 28.03.2025 18:01
What's more important, subretinal or intraretinal fluid? What markers indicate inflammation and fibrosis? Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002361?ecd=bdc_podcast_libsyn_mscpedu
Sharing Expert Minds in Lung Cancer and Lung Neuroendocrine Tumors Delivering Optimal Patient Care 20.03.2025 36:18
Did you know that lung neuroendocrine tumors (NETs) are often misdiagnosed as lung cancer due to overlapping imaging and histological features? Credit available for this activity expires: 3/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002284?ecd=bdc_podcast_libsyn_mscpedu
COVID-19 Antivirals: Real-World Evidence Review 18.03.2025 31:50
What can we learn from real-world studies on COVID-19 antivirals to improve outcomes for at-risk patients? Credit available for this activity expires: 3/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002326?ecd=bdc_podcast_libsyn_mscpedu
Podobne podcasty
Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS